1. Home
  2. SON vs TMDX Comparison

SON vs TMDX Comparison

Compare SON & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonoco Products Company

SON

Sonoco Products Company

HOLD

Current Price

$44.39

Market Cap

4.3B

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$122.08

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SON
TMDX
Founded
1899
1998
Country
United States
United States
Employees
N/A
728
Industry
Containers/Packaging
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.2B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
SON
TMDX
Price
$44.39
$122.08
Analyst Decision
Strong Buy
Buy
Analyst Count
7
8
Target Price
$56.83
$144.25
AVG Volume (30 Days)
886.5K
664.3K
Earning Date
02-17-2026
10-29-2025
Dividend Yield
4.86%
N/A
EPS Growth
116.52
170.70
EPS
6.30
2.54
Revenue
$7,114,053,000.00
$566,354,000.00
Revenue This Year
$45.34
$38.81
Revenue Next Year
N/A
$20.49
P/E Ratio
$23.56
$47.97
Revenue Growth
67.86
41.20
52 Week Low
$38.65
$55.00
52 Week High
$50.09
$156.00

Technical Indicators

Market Signals
Indicator
SON
TMDX
Relative Strength Index (RSI) 69.19 42.49
Support Level $42.96 $121.00
Resistance Level $44.10 $133.29
Average True Range (ATR) 0.66 4.77
MACD 0.09 -0.84
Stochastic Oscillator 97.01 21.89

Price Performance

Historical Comparison
SON
TMDX

About SON Sonoco Products Company

Over its 100-year-plus history, Sonoco Products has steadily assembled a diverse portfolio of industrial and consumer packaging product offerings such as flexible and rigid plastics, reels and spools, pallets, and composite cans. The company serves a variety of consumer and industrial end markets throughout North America. Sonoco has raised its dividend each year for more than 40 years.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: